The current COVID-19 pandemic is presenting exceptional and unprecedented challenges to our global community. At Curiox Biosystems, we are committed to assist those fighting against COVID-19 virus in every way possible and are dedicated to help advance the scientific research on COVID-19. More specifically, we are excited to announce the following advancements:

• AUTO 1000 System for a rapid, non-aerosolized, scalable and more effective vaccine development without centrifugation
• Novel blood processing technology to safely prepare COVID-19 samples for vaccine research with STEMCELL Technologies

We are responsible for our employees, customers, collaborators, and communities to ensure the smooth and continued support in keeping with the latest public advisories. While the current situation has brought an impact on our face-to-face interactions, we are always available to introduce our technology and to provide any relevant data to support your research.

We will continue to provide updates as the situation continues to evolve. If we can be of any assistance, please do not hesitate to contact us.